This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Roeltgen, D. P. Articles by Schneider, J. S. Search for Related Content PubMed PubMed Citation Articles by Roeltgen, D. P. Articles by Schneider, J. S. Social Bookmarking                         What's this?

Chronic Low-Dose MPTP in Nonhuman Primates: A Possible Model for Attention Deficit Disorder

Center for Neurological Research of the Department of Neurology and Institute of Neuroscience, Hahnemann University School of Medicine, Philadelphia, PA

Jay S. Schneider, PhD

Center for Neurological Research of the Department of Neurology and Institute of Neuroscience, Hahnemann University School of Medicine, Philadelphia, PA

Schneider and Kovelowski (1990) showed that chronic low-dose N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to monkeys caused cognitive dysfunction without significant motor impairment on tasks thought to be related to the caudate-frontal axis. The cognitive difficulties were similar to those seen in monkeys with frontal lesions, normal young monkeys, and normal young children. The caudate-frontal dysfunction is consistent with the cognitive difficulties that are thought to exist in children with attention deficit disorder (ADD). The caudate-frontal dysfunction is also consistent with the distribution of decreased cerebral blood flow and, presumably, decreased metabolism that has recently been found in children with ADD. In monkeys given chronic low-dose MPTP, pilot neurochemical studies have suggested abnormalities in dopamine and norepinephrine metabolism, the two neurotransmitters most frequently linked with ADD. We suggest that chronic low-dose MPTP induced cognitive dysfunction in primates may not only be a model for the cognitive disturbances that accompany Parkinson's disease but may also aid in understanding the cognitive dysfunction seen in children with ADD. (J Child Neurol 1991;6(Suppl):S80-S87).

Journal of Child Neurology, Vol. 6, No. 1 suppl, S82-S89 (1991)
DOI: 10.1177/0883073891006001101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. X. Castellanos Toward a Pathophysiology of Attention-Deficit/Hyperactivint Disorder Clinical Pediatrics, July 1, 1997; 36(7): 381 - 393. [Abstract] [PDF]